ELECTROCARDIOGRAPHIC LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH SUSPECTED ACUTE CARDIAC ISCHEMIA - ITS INFLUENCE ON DIAGNOSIS, TRIAGE, AND SHORT-TERM PROGNOSIS - A MULTICENTER STUDY
Gc. Larsen et al., ELECTROCARDIOGRAPHIC LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH SUSPECTED ACUTE CARDIAC ISCHEMIA - ITS INFLUENCE ON DIAGNOSIS, TRIAGE, AND SHORT-TERM PROGNOSIS - A MULTICENTER STUDY, Journal of general internal medicine, 9(12), 1994, pp. 666-673
Objective: To understand the diagnostic and short-term prognostic sign
ificance of electrocardiographic left ventricular hypertrophy (ECG-LVH
) for patients who present to the emergency department with symptoms s
uggesting acute cardiac ischemia, defined as new or unstable angina pe
ctoris or acute myocardial infarction. Design: Subgroup analysis of a
multicenter, prospective study of coronary care unit admitting practic
es in the prethrombolytic era. Setting: The emergency departments of s
ix New England hospitals: two urban medical school teaching hospitals,
two medical school-affiliated community hospitals in smaller cities,
and tow rural non-teaching hospitals. Patients: 5,768 patients present
ing with symptoms suggesting possible acute cardiac ischemia, includin
g 413 patients who had ECG-LVH defined by the Romhilt-Estes point scor
e criteria and 5,355 patients who had other electrocardiogram (ECG) fi
ndings. Main results: Only 26% of the 413 patients who had ECG-LVH wer
e ultimately judged to have had acute cardiac ischemia, compared with
72% of patients who had primary ST-segment and T-wave abnormalities (p
< 0.001) and 36% of those who had other ECG abnormalities (p < 0.001)
. Overall, the ECG-LVH patients were one-third less likely than the pa
tients who did not have ECG-LVH to have had acute cardiac ischemia, af
ter controlling for other predictors of acute ischemia by logistic reg
ression (relative risk = 0.66, 95% CI 0.46 to 0.94). The patients who
had ECG-LVH were only one-fourth as likely to have had acute myocardia
l infarctions as were the patients presenting with primary ST-segmnt a
nd T-wave changes (12% vs 48%, p < 0.001). Instead, a much larger prop
ortion had had congestive heart failure or hypertension. The admitting
physicians had identified ECG-LVH poorly on the admitting ECGs: only
22% of those who had ECG-LVH had been correctly identified, and for mo
re than 70%, the secondary ST-segment and T-wave changes of ECG-LVH ha
d been read as being primary. The short-term mortality for the patient
s who had ECG-LVH was 7.5%. This was intermediate between the mortalit
y for patients who had primary ST-segment and T-wave abnormalities (10
.6%) and those who had other ECG abnormalities (5.1%). Mortality was n
ot affected by whether the admitting physician had recognized ECG-LVH
initially. Conclusion: ECG-LVH was not a benign ECG finding among the
patients who had presented with symptoms suggesting an acute cardiac i
schemic syndrome: short-term mortality among the patients who had ECG-
LVH (7.5%) approached that for the patients who had primary ST-segment
and T-wave abnormalities (10.6%, p = 0.10). However, the patients who
had ECG-LVH were one-third less likely to have had any acute cardiac
ischemia than were the patients who did not have ECG-LVH, after logist
ic regression was used to control for other predictors of acute ischem
ia. Specifically, acute myocardial infarction was only one-fourth as l
ikely when LVH was present on the admitting ECG (12%) as it was when p
rimary ST-segment and T-wave abnormalities were present (48%, p < 0.00
1). Instead, congestive heart failure and hypertensive heart disease w
ere more common. Thus, routine use of thrombolytic therapy for patient
s who have ECG-LVH does not seem warranted. ECG-LVH was poorly recogni
zed (in only 22% of cases) by the physicians in the present study. Bet
ter recognition of this common ECG finding may lead to more effective
patient management.